Industries de la santé
12 Septembre 2011
Initial Animal Studies Suggest that PLX Cells Can Increase Survival Rates Following Exposure to Lethal Doses of Radiation |HAIFA, ISRAEL, September 7, 2011 -- Pluristem Therapeutics Inc. (NasdaqCM: PSTI; TASE: PLTR) announced today that animal studies it has conducted suggest that its PLacental eXpanded (PLX) cells are potentially effective in treating life threatening hematopoietic...